Home > Research Divisions > Research Center for Charged Particle Therapy >
This group consists of the Clinical Trial Research Team,
Clinical Database Research Team, and Radiation Effect Research Team. It does
research and development on charged particle therapy.
Major research areas
- Extending the applications for charged
particle cancer therapy
Clinical studies to develop therapeutic techniques for diseases that are difficult
to treat with other therapies (such as pancreatic cancer) and for which charged
particle radiation therapy does not yet have a role.
- Development of more effective and more
efficient therapeutic methods with lower risks
A study on optimizing irradiation methods by disease and by region, using
clinical investigations of therapies in which radiation is combined with
drugs and operations
- Development of a database
Development of a comprehensive database on treatment, clinical course and
other factors. Comparison and analysis of domestic and foreign data on
particle beam
therapy.
- Extending the number of treatments to
disseminate the therapeutic technology
To maximize and disseminate the therapeutic effect of charged particle
technology, five hundred patients are to be treated annually. This is the
target number
combining patients taking part in clinical studies and those receiving
high-technology treatments, in consideration of the fact that the NIRS
is primarily a research
and development facility.
- Estimation of therapeutic effects
The therapeutic effects of treatments developed by the Institute are evaluated
from the viewpoint of quality of life (QOL) and therapeutic costs. Patients'
opinions are collected to gauge their level of satisfaction with the therapy.